ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,194Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 570

$1.93M Total Retail Price of All Prescriptions

Rank: 6 out of 570

678 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 678 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

15% of this provider’s 678 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 20,672 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 52%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $124 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 886 632 1 8
AMLODIPINE BESYLATE 737 663 2 7
SIMVASTATIN 727 624 3 6
METFORMIN HCL 615 537 4 14
DONEPEZIL HCL 604 588 5 35
LISINOPRIL 594 551 6 11
OMEPRAZOLE 590 465 7 5
WARFARIN SODIUM 514 390 8 16
NAMENDA 509 496 9 50
METOPROLOL TARTRATE 435 389 10 18
DIVALPROEX SODIUM 423 306 11 98
FUROSEMIDE 400 311 12 10
RISPERIDONE 392 222 13 73
RANITIDINE HCL 376 290 14 88
IPRATROPIUM-ALBUTEROL 374 312 15 100
QUETIAPINE FUMARATE 326 257 16 97
HYDROCODONE-ACETAMINOPHEN 311 244 S3 17 9
TRIAMCINOLONE ACETONIDE 279 241 18 62
TAMSULOSIN HCL 279 245 18 37
OLANZAPINE 272 179 20 143
POTASSIUM CHLORIDE 270 233 21 24
GABAPENTIN 266 172 22 25
MIRTAZAPINE 258 244 23 65
LEVETIRACETAM 256 160 24 67
ALENDRONATE SODIUM 240 219 25 28
GLIMEPIRIDE 233 230 26 76
TRAVATAN Z 233 205 26 188
BENZTROPINE MESYLATE 228 108 R 28 126
LANTUS 227 162 29 52
SERTRALINE HCL 225 209 30 61
ZOLPIDEM TARTRATE 221 196 31 17
NYSTATIN 210 156 32 147
CARBIDOPA-LEVODOPA 190 177 33 99
VALPROIC ACID 186 99 34 142
NOVOLIN R 183 148 35 121
ATENOLOL 178 137 36 22
ATORVASTATIN CALCIUM 161 142 37 20
TRAZODONE HCL 159 115 38 80
LOSARTAN POTASSIUM 157 136 39 23
METOPROLOL SUCCINATE 156 156 40 44
CLOPIDOGREL 155 150 41 48
DIOVAN 153 141 42 27
CARVEDILOL 144 118 43 33
FLUOCINONIDE 142 119 44 157
FAMOTIDINE 140 124 45 41
PANTOPRAZOLE SODIUM 139 93 46 21
CITALOPRAM HBR 138 118 47 82
ALBUTEROL SULFATE 137 90 48 30
SEROQUEL 131 108 49 246
FENOFIBRATE 131 99 49 109
DIVALPROEX SODIUM ER 128 75 51 249
BACLOFEN 126 63 52 84
DIGOXIN 123 111 53 46
TRAMADOL HCL 123 72 53 31
SANTYL 121 72 55 138
BRIMONIDINE TARTRATE 119 115 56 261
CYMBALTA 116 90 57 93
HYDROXYZINE HCL 112 100 R 58 203
MEGESTROL ACETATE 106 103 R 59 63
JANUVIA 103 88 60 58
HALOPERIDOL 103 23 60 216
NOVOLOG 101 88 62 104
ISOSORBIDE MONONITRATE ER 101 99 62 89
CLOTRIMAZOLE 101 60 62 171
ESCITALOPRAM OXALATE 98 86 65 72
PROPRANOLOL HCL 98 39 65 229
HUMALOG 97 87 67 125
LITHIUM CARBONATE 96 50 68 281
PERMETHRIN 95 86 69 220
PAROXETINE HCL 95 82 69 79
ECONAZOLE NITRATE 95 91 69 282
TRICOR 95 87 69 151
EXELON 93 93 73 242
ENOXAPARIN SODIUM 92 44 74 148
CLOZAPINE 90 31 75 240
LACTULOSE 89 24 76 90
POLYETHYLENE GLYCOL 3350 89 54 76 111
HYDROCHLOROTHIAZIDE 88 87 78 26
GLIPIZIDE 88 76 78 51
PROCRIT 87 26 80 200
CELEBREX 86 79 81 102
CEPHALEXIN 86 71 81 103
FLUOXETINE HCL 86 84 81 94
SPIRIVA 85 69 84 1
METOCLOPRAMIDE HCL 84 39 85 81
LEVEMIR 83 80 86 180
LUMIGAN 83 83 86 291
DILTIAZEM 24HR CD 81 81 88 136
PLAVIX 81 77 88 68
CLOTRIMAZOLE-BETAMETHASONE 81 76 88 152
FINASTERIDE 80 66 91 106
SILVER SULFADIAZINE 79 78 92 294
SULFAMETHOXAZOLE-TRIMETHOPRIM 79 57 92 59
PHENYTOIN SODIUM EXTENDED 77 41 94 130
IPRATROPIUM BROMIDE 76 71 95 39
AVODART 76 64 95 247
LAMOTRIGINE 72 59 97 182
ABILIFY 72 52 97 251
LEVOFLOXACIN 71 55 99 32
NEXIUM 71 56 99 45
DOXAZOSIN MESYLATE 70 70 101 110
AMOX TR-POTASSIUM CLAVULANATE 70 56 101 106
ATELVIA 69 69 103 308
PREDNISONE 67 50 104 3
HUMULIN R 66 56 105 163
SEROQUEL XR 65 53 106 261
ADVAIR DISKUS 65 63 106 2
GLYBURIDE 65 35 R 106 71
HEPARIN SODIUM 64 43 109 74
IBUPROFEN 62 0 110 53
PHENYTOIN 61 27 111 168
PRAVASTATIN SODIUM 61 40 111 43
CHLORHEXIDINE GLUCONATE 60 39 113 211
BENAZEPRIL HCL 60 60 113 42
FLUTICASONE PROPIONATE 59 42 115 19
ACETYLCYSTEINE 59 59 115 328
TRIFLUOPERAZINE HCL 59 24 115 328
LATANOPROST 59 59 115 255
DILTIAZEM HCL 58 43 119 273
ALLOPURINOL 58 57 119 55
NOVOLIN N 56 39 121 337
OXYCODONE-ACETAMINOPHEN 56 31 S2 121 235
LOVAZA 55 38 123 153
TERAZOSIN HCL 53 41 124 105
CIPROFLOXACIN HCL 53 44 124 56
BYSTOLIC 52 51 126 210
SPIRONOLACTONE 51 45 127 77
LOVASTATIN 51 51 127 34
FOSINOPRIL SODIUM 50 47 129 358
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.